Galectin-1beta, a natural monomeric form of galectin-1 lacking its six amino-terminal residues promotes axonal regeneration but not cell death

Cell Death Differ. 2004 Oct;11(10):1076-83. doi: 10.1038/sj.cdd.4401462.

Abstract

We previously identified a novel N-terminally processed form of galectin-1, galectin-1beta (Gal-1beta) whose expression was induced by DeltaFosB. In the present study, the biochemical properties and biological functions of Gal-1beta were compared with the full-length form of galectin-1 (Gal-1alpha). We first purified recombinant mouse Gal-1alpha and beta (rmGal-1alpha, beta) to near homogeneity. The rmGal-1alpha exists as a monomer under oxidized conditions and forms a dimer under reduced conditions, while the rmGal-1beta exists as a monomer regardless of redox conditions. The affinity of rmGal-1beta to beta-lactose was approximately two-fold lower than that of rmGal-1alpha under reduced conditions. The viability of Jurkat cells efficiently decreased when they were exposed to rmGal-1alpha, however, rmGal-1beta barely induced such a reduction. In contrast, both rmGal-1alpha and rmGal-1beta exhibited an equivalent capacity to promote axonal regeneration from the dorsal root ganglion explants. Our results suggest that the biochemical properties of rmGal-1beta determine its biological functions.

MeSH terms

  • Animals
  • Axons / drug effects*
  • Axons / metabolism*
  • Cell Death / drug effects
  • Circular Dichroism
  • Dimerization
  • Galectin 1 / chemistry*
  • Galectin 1 / genetics
  • Galectin 1 / metabolism
  • Galectin 1 / pharmacology*
  • Ganglia, Spinal / cytology
  • Ganglia, Spinal / drug effects
  • Ganglia, Spinal / metabolism
  • Humans
  • Jurkat Cells
  • Lectins / pharmacology
  • Mice
  • Models, Molecular
  • Nerve Regeneration / drug effects*
  • Oxidation-Reduction
  • Protein Structure, Secondary
  • Protein Structure, Tertiary
  • Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization
  • Structure-Activity Relationship

Substances

  • Galectin 1
  • Lectins